Compounds > docetaxel anhydrous
Page last updated: 2024-09-04

docetaxel anhydrous and dolutegravir

docetaxel anhydrous has been researched along with dolutegravir in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)		Trials
(docetaxel anhydrous)		Recent Studies (post-2010)
(docetaxel anhydrous)		Studies
(dolutegravir)		Trials
(dolutegravir)		Recent Studies (post-2010) (dolutegravir)
12,1103,2166,9201,1281791,105

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)dolutegravir (IC50)
Chain A, PFV integraseHuman spumaretrovirus0.0517
Chain A, PFV integraseHuman spumaretrovirus0.0517
Chain A, PFV integraseHuman spumaretrovirus0.0517
Solute carrier family 22 member 2Homo sapiens (human)1.9
Integrase Human immunodeficiency virus 10.0414

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bojko, P; Hentrich, M; Jäger, H; Schipek-Voigt, K; Schmid, P; Schulz, S; Stötzer, O1

Other Studies

1 other study(ies) available for docetaxel anhydrous and dolutegravir

ArticleYear
Nivolumab in HIV-related non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 11-01, Volume: 28, Issue:11

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; CD4 Lymphocyte Count; Cisplatin; Darunavir; Deoxycytidine; Docetaxel; Gemcitabine; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lung Neoplasms; Male; Middle Aged; Nivolumab; Oxazines; Piperazines; Pyridones; Ritonavir; Vinorelbine

2017